269 related articles for article (PubMed ID: 18486198)
21. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
Thromb Haemost; 2004 Mar; 91(3):480-6. PubMed ID: 14983223
[TBL] [Abstract][Full Text] [Related]
22. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Adv Med Sci; 2008; 53(1):32-6. PubMed ID: 18635422
[TBL] [Abstract][Full Text] [Related]
23. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases.
Chamouard P; Grunebaum L; Wiesel ML; Frey PL; Wittersheim C; Sapin R; Baumann R; Cazenave JP
Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1183-8. PubMed ID: 8789309
[TBL] [Abstract][Full Text] [Related]
24. Enhanced thrombin generation and depressed anticoagulant function in children with pneumonia.
Långström S; Peltola V; Petäjä J; Ruuskanen O; Heikinheimo M
Acta Paediatr; 2012 Sep; 101(9):919-23. PubMed ID: 22646857
[TBL] [Abstract][Full Text] [Related]
25. Outer membrane vesicles alter inflammation and coagulation mediators.
Soult MC; Dobrydneva Y; Wahab KH; Britt LD; Sullivan CJ
J Surg Res; 2014 Nov; 192(1):134-42. PubMed ID: 24909870
[TBL] [Abstract][Full Text] [Related]
26. The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders.
Arkel YS; Paidas MJ; Ku DH
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):199-205. PubMed ID: 11943933
[TBL] [Abstract][Full Text] [Related]
27. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
[TBL] [Abstract][Full Text] [Related]
28. Orthostatic hypercoagulability: a novel physiological mechanism to activate the coagulation system.
Masoud M; Sarig G; Brenner B; Jacob G
Hypertension; 2008 Jun; 51(6):1545-51. PubMed ID: 18413485
[TBL] [Abstract][Full Text] [Related]
29. Thyroid function, endothelium, and inflammation in hemodialyzed patients: possible relations?
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
J Ren Nutr; 2007 Jan; 17(1):30-7. PubMed ID: 17198929
[TBL] [Abstract][Full Text] [Related]
30. Plasma hypercoagulability in haemodialysis patients: impact of dialysis and anticoagulation.
Ambühl PM; Wüthrich RP; Korte W; Schmid L; Krapf R
Nephrol Dial Transplant; 1997 Nov; 12(11):2355-64. PubMed ID: 9394323
[TBL] [Abstract][Full Text] [Related]
31. Tissue factor/factor VIIa pathway mediates coagulation activation in induced-heat stroke in the baboon.
Bouchama A; Al-Mohanna F; Assad L; Baturcam E; Eldali A; Owaidah T; Dehbi M
Crit Care Med; 2012 Apr; 40(4):1229-36. PubMed ID: 22080642
[TBL] [Abstract][Full Text] [Related]
32. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
[TBL] [Abstract][Full Text] [Related]
33. Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.
Erdem Y; Haznedaroglu IC; Celik I; Yalcin AU; Yasavul U; Turgan C; Caglar S
Nephrol Dial Transplant; 1996 Jul; 11(7):1299-305. PubMed ID: 8672026
[TBL] [Abstract][Full Text] [Related]
34. Assessment of coagulation factor activation during cardiopulmonary bypass with a new monoclonal antibody.
Journois D; Mauriat P; Pouard P; Marchot P; Amiral J; Safran D
J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):157-61. PubMed ID: 8204808
[TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
[TBL] [Abstract][Full Text] [Related]
36. Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors.
Canales MA; Arrieta R; Gomez-Rioja R; Diez J; Jimenez-Yuste V; Hernandez-Navarro F
J Hematother Stem Cell Res; 2002 Aug; 11(4):675-81. PubMed ID: 12201956
[TBL] [Abstract][Full Text] [Related]
37. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity.
Stam F; van Guldener C; Schalkwijk CG; ter Wee PM; Donker AJ; Stehouwer CD
Nephrol Dial Transplant; 2003 May; 18(5):892-8. PubMed ID: 12686661
[TBL] [Abstract][Full Text] [Related]
38. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
39. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
Joly B; Barbay V; Borg JY; Le Cam-Duchez V
Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
[TBL] [Abstract][Full Text] [Related]
40. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
